Drug recall · September 6, 2017
Amoxicillin and Clavulanate Potassium for Oral Suspension recall
Why: Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when reconstituted) bottle, Rx Only, Manufactured By: Cipla Ltd. at Medispray Laboratories Pvt. Ltd., Kundaim Goa, India; Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054, NDC 60432-065-00.
- Lots / codes
Batch #: KH60276, Exp 10/18
- Quantity
- 7332 bottles
- Company
- Morton Grove Pharmaceuticals, Inc., Morton Grove, IL
- Distribution
- Nationwide in the USA and Puerto Rico.
- Initiated
- August 10, 2017 · Voluntary: Firm initiated
- Classified
- August 29, 2017
- Reported
- September 6, 2017
- Ended
- September 13, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amoxicillin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.